<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>NNC-711 [1-(2-((diphenylmethylene)amino)oxy)ethyl)-1,2,4,6-tetrahydro-3-pyridinecarboxylic acid <z:chebi fb="16" ids="36807">hydrochloride</z:chebi>], a <z:chebi fb="0" ids="16865">gamma-aminobutyric acid</z:chebi> (<z:chebi fb="3" ids="16865">GABA</z:chebi>) reuptake inhibitor with <z:chebi fb="0" ids="35623">anticonvulsant</z:chebi> activity, was investigated with respect to its cognition-enhancing and neuroprotective potency </plain></SENT>
<SENT sid="1" pm="."><plain>In the rat, administration of NNC-711 immediately prior to training prevented <z:e sem="disease" ids="C0002622" disease_type="Mental or Behavioral Dysfunction" abbrv="">amnesia</z:e> for a passive avoidance task induced by the <z:chebi fb="0" ids="48873">acetylcholine receptor antagonist</z:chebi> <z:chebi fb="2" ids="16794">scopolamine</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>NNC-711 was also effective in protecting against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced <z:hpo ids='HP_0011420'>death</z:hpo> of CA1 pyramidal neurons in a model of bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> in the gerbil </plain></SENT>
<SENT sid="3" pm="."><plain>In addition to a neuroprotective activity, NNC-711 exhibited significant cognition-enhancing actions </plain></SENT>
<SENT sid="4" pm="."><plain>Daily administration of NNC-711, immediately prior to a spatial learning task, significantly reduced escape latencies in the water maze paradigm in both mature (postnatal day 80) and aged (28 months) rats </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of the above actions exhibited a bell-shaped response with an optimal dose of 0.5-1.0 mg/kg </plain></SENT>
<SENT sid="6" pm="."><plain>These investigations with NNC-711 and previous clinical observations on the structurally related <z:chebi fb="0" ids="35623">anticonvulsant</z:chebi> tiagabine confirm the potential of <z:chebi fb="3" ids="16865">GABA</z:chebi> reuptake inhibitors as anti-<z:e sem="disease" ids="C0002622" disease_type="Mental or Behavioral Dysfunction" abbrv="">amnesia</z:e> and cognition-enhancing agents </plain></SENT>
</text></document>